Satya Pharma Innovations Private Limited
Satya Pharma Innovations is an oncology biotech company focused on developing mechanism-agnostic targeted therapies across various indications. They leverage AI-driven insights combined with traditional drug discovery to identify and modulate key biological processes such as cell cycle, DNA repair, and cell metabolism. Their pipeline includes first-in-class and best-in-class programs targeting diseases like cancer, inflammation, and metabolic disorders. Key areas of focus include inhibiting RAD51:BRCA2 for PARPi-resistant cancers, developing differentiated covalent PARG inhibitors, and exploring SOS1 inhibitors for KRAS and EGFR driven tumors. They are also investigating novel targets for oncology and inflammatory disorders, and developing alternative obesity treatments. The company has a strong scientific team with extensive experience in drug discovery and development, aiming to create transformative therapies for diseases impacting millions.
Satya Pharma Innovations Private Limited
Satya Pharma Innovations is an oncology biotech company focused on developing mechanism-agnostic targeted therapies across various indications. They leverage AI-driven insights combined with traditional drug discovery to identify and modulate key biological processes such as cell cycle, DNA repair, and cell metabolism. Their pipeline includes first-in-class and best-in-class programs targeting diseases like cancer, inflammation, and metabolic disorders. Key areas of focus include inhibiting RAD51:BRCA2 for PARPi-resistant cancers, developing differentiated covalent PARG inhibitors, and exploring SOS1 inhibitors for KRAS and EGFR driven tumors. They are also investigating novel targets for oncology and inflammatory disorders, and developing alternative obesity treatments. The company has a strong scientific team with extensive experience in drug discovery and development, aiming to create transformative therapies for diseases impacting millions.